This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Hoffmann Neopac has appointed two new co-directors to lead its U.S. facility in Wilson, N.C., which until recently focused mostly on small-diameter tubes for the pharmaceutical sector. Friedrich Holz was hired as director of finance & administration and will co-lead the facility alongside Jonathan Tedder, who was promoted to director of operations. The appointments come as Neopac plans to increase its tube production capacity in 2024, including a new focus on larger-diameter tubes applicable to the cosmetics sector.
The facility’s expanded market focus will entail the installation of a new tube line producing tubes 25 to 40 mm in diameter, with an output capacity of 40 million tubes annually. The line will mainly target the consumer health and cosmetic industries, manufacturing both high-barrier Polyfoil® and recyclable Polyfoil® MMB mono-material tubes.
Holz joins Hoffmann Neopac with more than 20 years of experience in managing internal controls and financial operations within the manufacturing industry. Most recently, he was chief financial officer at Haag-Streit, a medical device company in the eyecare field. Prior to that, Holz held numerous senior-level finance positions for more than a decade at Silicon Microstructures, a manufacturer of high-end pressure sensors for automotive, medical, and industrial applications.
Tedder joined Hoffmann Neopac in 2019 as head of production and, for several years, oversaw the Wilson plant’s machinery to ensure safety, quality, and productivity. He was promoted to his new role of director of operations this May.
Holz and Tedder’s new roles coincide with the retirement of outgoing Managing Director Douglas Voreis, who oversaw the U.S. facility’s initial build and ramp-up as it began and expanded production of small-diameter pharmaceutical tubes.